Thrombosis after SARS-CoV2 infection or COVID-19 vaccination: will a nonpathologic anti-PF4 antibody be a solution?—A narrative review

Elizabeth Rao, Payal Grover, Hongtao Zhang

Open source

DOI
10.1097/jbr.0000000000000125
Published
2022-08-29
Container
Journal of Bio-X Research
Publisher
American Association for the Advancement of Science (AAAS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/jbr.0000000000000125,
  title = {Thrombosis after SARS-CoV2 infection or COVID-19 vaccination: will a nonpathologic anti-PF4 antibody be a solution?—A narrative review},
  author = {Elizabeth Rao and Payal Grover and Hongtao Zhang},
  year = {2022},
  journal = {Journal of Bio-X Research},
  doi = {10.1097/jbr.0000000000000125},
  url = {https://doi.org/10.1097/jbr.0000000000000125}
}

RIS

TY  - JOUR
TI  - Thrombosis after SARS-CoV2 infection or COVID-19 vaccination: will a nonpathologic anti-PF4 antibody be a solution?—A narrative review
AU  - Elizabeth Rao
AU  - Payal Grover
AU  - Hongtao Zhang
PY  - 2022
JO  - Journal of Bio-X Research
DO  - 10.1097/jbr.0000000000000125
UR  - https://doi.org/10.1097/jbr.0000000000000125
ER  - 

APA

Rao, E., Grover, P., & Zhang, H. (2022). Thrombosis after SARS-CoV2 infection or COVID-19 vaccination: will a nonpathologic anti-PF4 antibody be a solution?—A narrative review. Journal of Bio-X Research. https://doi.org/10.1097/jbr.0000000000000125

Source records